The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for structural heart disease
Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation
EuroIntervention 2014;10:860 published online ahead of print January 2014. DOI: 10.4244/EIJV10I7A146
Roel J.R. Snijder, MD; Martijn C. Post*, MD, PhD; Maarten J. Suttorp, MD, PhD
Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
A 49-year-old woman, with a history of cryptogenic stroke and percutaneous patent foramen ovale (PFO) closure using a bioabsorbable device with a diameter of 28 mm, was seen in our outpatient clinic for contrast transthoracic echocardiography (TTE) at three-year follow-up. Earlier contrast TTE had shown a small right-to-left shunt. Currently, her clinical investigation was unremarkable. The TTE showed a good device position, without thrombi on the device. Colour Doppler showed no signs of shunting, but using contrast (Figure 1A) a severe right-to-left shunt was diagnosed during Valsalva. Under local anaesthesia and intracardiac echocardiographic guidance, the residual shunt was closed percutaneously using ...